Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Sale
Class A Common Stock
2026-01-06$4.36/sh−220,000$959,200→ 6,649,863 total
Footnotes (1)
- [F1]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.